Apiam Animal Health Management
Management criteria checks 4/4
Apiam Animal Health's CEO is Chris Richards, appointed in Nov 2015, has a tenure of 9.08 years. total yearly compensation is A$595.67K, comprised of 72.5% salary and 27.5% bonuses, including company stock and options. directly owns 22.79% of the company’s shares, worth A$15.60M. The average tenure of the management team and the board of directors is 4.1 years and 9.1 years respectively.
Key information
Chris Richards
Chief executive officer
AU$595.7k
Total compensation
| CEO salary percentage | 72.5% |
| CEO tenure | 9.1yrs |
| CEO ownership | 22.8% |
| Management average tenure | 4.1yrs |
| Board average tenure | 9.1yrs |
Recent management updates
Recent updates
There's Reason For Concern Over Apiam Animal Health Limited's (ASX:AHX) Price
Aug 08
Subdued Growth No Barrier To Apiam Animal Health Limited (ASX:AHX) With Shares Advancing 30%
Feb 24These 4 Measures Indicate That Apiam Animal Health (ASX:AHX) Is Using Debt Extensively
Oct 12Apiam Animal Health (ASX:AHX) Has Announced That Its Dividend Will Be Reduced To A$0.004
Sep 02Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012
Feb 28Here's Why We Think Apiam Animal Health Limited's (ASX:AHX) CEO Compensation Looks Fair for the time being
Nov 18Apiam Animal Health (ASX:AHX) Has Announced A Dividend Of AU$0.012
Sep 15Apiam Animal Health (ASX:AHX) Has Re-Affirmed Its Dividend Of AU$0.012
Sep 01A Look At The Fair Value Of Apiam Animal Health Limited (ASX:AHX)
Jun 10With EPS Growth And More, Apiam Animal Health (ASX:AHX) Is Interesting
Apr 16Only Four Days Left To Cash In On Apiam Animal Health's (ASX:AHX) Dividend
Mar 14Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 43% Above Its Share Price
Mar 12Should You Or Shouldn't You: A Dividend Analysis on Apiam Animal Health Limited (ASX:AHX)
Feb 25How Is Apiam Animal Health's (ASX:AHX) CEO Compensated?
Feb 08
Should Weakness in Apiam Animal Health Limited's (ASX:AHX) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Jan 18Does Apiam Animal Health (ASX:AHX) Have A Healthy Balance Sheet?
Dec 28Apiam Animal Health Limited's (ASX:AHX) Intrinsic Value Is Potentially 91% Above Its Share Price
Dec 11Is Apiam Animal Health Limited (ASX:AHX) The Right Choice For A Smart Dividend Investor?
Nov 24CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | AU$5m |
| Mar 31 2024 | n/a | n/a | AU$4m |
| Dec 31 2023 | n/a | n/a | AU$3m |
| Sep 30 2023 | n/a | n/a | AU$2m |
| Jun 30 2023 | AU$596k | AU$432k | AU$2m |
| Mar 31 2023 | n/a | n/a | AU$4m |
| Dec 31 2022 | n/a | n/a | AU$6m |
| Sep 30 2022 | n/a | n/a | AU$5m |
| Jun 30 2022 | AU$505k | AU$368k | AU$5m |
| Mar 31 2022 | n/a | n/a | AU$4m |
| Dec 31 2021 | n/a | n/a | AU$4m |
| Sep 30 2021 | n/a | n/a | AU$5m |
| Jun 30 2021 | AU$455k | AU$361k | AU$5m |
| Mar 31 2021 | n/a | n/a | AU$5m |
| Dec 31 2020 | n/a | n/a | AU$5m |
| Sep 30 2020 | n/a | n/a | AU$5m |
| Jun 30 2020 | AU$401k | AU$355k | AU$4m |
| Mar 31 2020 | n/a | n/a | AU$4m |
| Dec 31 2019 | n/a | n/a | AU$3m |
| Sep 30 2019 | n/a | n/a | AU$3m |
| Jun 30 2019 | AU$389k | AU$350k | AU$3m |
| Mar 31 2019 | n/a | n/a | AU$3m |
| Dec 31 2018 | n/a | n/a | AU$3m |
| Sep 30 2018 | n/a | n/a | AU$3m |
| Jun 30 2018 | AU$396k | AU$350k | AU$3m |
Compensation vs Market: Chris's total compensation ($USD372.55K) is about average for companies of similar size in the Australian market ($USD291.73K).
Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.
CEO
Chris Richards
9.1yrs
Tenure
AU$595,673
Compensation
Dr. Christopher Irwin Richards, also known as Chris, BSc, BVSc, MAICD, has been Managing Director of Apiam Animal Health Limited since November 1, 2015. Dr. Richards founded Chris Richards & Associates in...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 9.1yrs | AU$595.67k | 22.79% A$ 15.6m | |
| Chief Financial Officer | no data | AU$347.51k | 0.25% A$ 173.1k | |
| Chief People Officer | no data | AU$258.44k | 0.093% A$ 63.3k | |
| Chief Veterinary Officer | less than a year | no data | 0.60% A$ 412.9k | |
| Company Secretary | 4.1yrs | no data | no data |
4.1yrs
Average Tenure
Experienced Management: AHX's management team is considered experienced (4.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| MD & Executive Director | 9.8yrs | AU$595.67k | 22.79% A$ 15.6m | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Chairman | 9.1yrs | AU$140.00k | 0.19% A$ 132.5k | |
| Independent Non-Executive Director | 2.2yrs | AU$52.50k | no data | |
| Independent Non-Executive Director | 9.1yrs | AU$80.00k | 0.0069% A$ 4.8k |
9.1yrs
Average Tenure
Experienced Board: AHX's board of directors are considered experienced (9.1 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 23:22 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Apiam Animal Health Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Russell Wright | Barclay Pearce Capital Pty Limited |
| Louis Bannon | CCZ Equities Pty Limited |
| Jonathon Higgins | Shaw and Partners Limited |